Inscripta’s team on the bioeconomy: engineering yeast and bacteria in fermentation tanks to produce medicines, agricultural products and cosmetics at industrial scale.
NEW BOOK The Invisible Interface Harry Glorikian’s new book explores…
NEW BOOK The Invisible Interface Harry Glorikian’s new book explores…
1910 Genetics founder and CEO Jen Nwankwo on where machine learning genuinely speeds up drug discovery, from target identification through preclinical testing, and how startup funding has shifted.
Cry Me a Biomarker: Using Tears to Screen for Cancer…
Insilico Brings Generative AI to Drug Development and Discovery Episode…
Raphael Townshend on The Power of Small Molecule Drugs Episode…
My TEDxBoston Speech is Coming Soon 🎙 Giving a TED…